Lawmakers expressed bipartisan support for reauthorizing an FDA program that helps streamline the process for bringing nonprescription drugs to market during a hearing of the Senate Health, Education, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback